Knee osteoarthritis is the most common joint condition in the UK — and one of the leading causes of pain, disability and reduced quality of life in adults over 45. Yet despite its prevalence, there remains widespread confusion about what knee osteoarthritis actually is, what causes it, and — crucially — what can be done about it beyond waiting for a joint replacement.
This guide covers everything you need to know: from the anatomy of the knee and how osteoarthritis develops, to the full spectrum of treatment options available today — including the latest injection therapies available at our clinics in London.
Osteoarthritis (OA) is a degenerative joint disease characterised by the progressive breakdown of articular cartilage — the smooth, rubbery tissue that covers the ends of bones within a joint. In a healthy knee, this cartilage allows the femur (thigh bone), tibia (shin bone), and patella (kneecap) to glide over one another with minimal friction. It also acts as a shock absorber, distributing load across the joint during walking, running, and everyday movement.
In knee osteoarthritis, this cartilage gradually thins, softens, and fragments. As the protective layer wears away, the underlying bone becomes exposed and begins to change in response to increased stress — forming bone spurs (osteophytes), thickening (sclerosis), and sometimes developing fluid-filled cysts. The joint's lining (synovium) becomes inflamed, contributing further to pain and swelling.
The result is a joint that is stiff, painful, and progressively less functional. Knee OA is not simply "wear and tear" — it is a complex biological process involving mechanical, inflammatory, and genetic factors — and it is one that can be meaningfully managed at every stage.
Knee OA affects an estimated 4.7 million people in England alone. Globally, it is the most common form of osteoarthritis and one of the leading causes of disability in older adults. Prevalence rises sharply with age — affecting around 10% of adults over 55 and nearly 50% of those over 75 — but it is increasingly diagnosed in younger adults, particularly those with a history of sporting injury, obesity, or prior knee surgery.
Women are approximately twice as likely as men to develop knee osteoarthritis, particularly after the menopause — a pattern that suggests hormonal factors play a role in cartilage health.
Knee osteoarthritis is not caused by a single factor. It develops when cumulative mechanical stress, biological vulnerability, and environmental risk factors combine to overwhelm the knee's natural capacity for repair. Understanding the causes helps explain both why OA develops and how certain treatments work to slow its progression.
Knee OA symptoms typically develop gradually over months to years. They are often first noticed during or after physical activity and may fluctuate significantly — with periods of relative calm punctuated by painful flare-ups.
Diagnosis of knee OA combines clinical assessment with imaging. A thorough evaluation is important not only to confirm the diagnosis but to characterise its severity, identify which compartments of the knee are most affected, and rule out other causes of knee pain — including meniscal tears, bursitis, ligament injury, and inflammatory arthritis.
A skilled clinician will assess your gait, observe the alignment of the knee, palpate for tenderness and bony enlargement, measure range of motion, test joint stability, and evaluate muscle strength. Specific clinical tests can help identify whether other structures — such as the menisci or ligaments — are contributing to symptoms.
Plain X-ray is the standard first-line imaging investigation for suspected knee OA. It is used to assess four key features:
X-ray appearances are graded using the Kellgren-Lawrence (KL) scale from 0 (normal) to 4 (severe bone-on-bone OA). It is important to note that the severity of X-ray changes does not always correlate with the severity of symptoms — some patients with marked radiological OA have relatively mild pain, while others with early changes experience significant disability.
MRI provides detailed images of cartilage, menisci, ligaments, and bone. It is particularly useful when the diagnosis is uncertain, when symptoms seem out of proportion to X-ray findings, or when a concurrent soft tissue injury (such as a meniscal tear) is suspected and may require separate management.
Diagnostic ultrasound can detect joint effusion (excess fluid), synovial thickening, and Baker's cysts (fluid-filled swellings behind the knee). At Joint Care London, ultrasound is also used in real time to guide all knee injections, ensuring precise, accurate medication delivery.
Understanding the stage of knee OA helps guide treatment decisions. The Kellgren-Lawrence grading system is the most widely used classification:
Most non-surgical treatments — including injection therapies — are most effective in grades 2 and 3, where meaningful cartilage and joint space remain.
Knee osteoarthritis cannot currently be cured — cartilage does not fully regenerate. However, a wide range of evidence-based treatments can significantly reduce pain, restore function, slow progression, and delay or potentially avoid the need for surgery. Treatment is most effective when tailored to the individual, taking into account the severity of OA, the patient's symptoms, lifestyle, activity goals, and overall health.
For most patients, lifestyle changes form the essential foundation of knee OA management. These interventions are the most evidence-based of all treatments for OA and carry no side effect profile.
A structured physiotherapy programme is one of the most effective long-term interventions for knee OA. The primary goal is strengthening the muscles that support and stabilise the knee — particularly the quadriceps, hamstrings, and hip abductors — to reduce the mechanical load placed on the joint surface itself.
Physiotherapy for knee OA typically includes:
A commitment of 8–12 weeks of regular physiotherapy is typically required before meaningful benefits are established. Crucially, exercise therapy does not wear the joint out further — in fact, moderate loading stimulates cartilage metabolism and is essential for long-term joint health.
Oral analgesics and anti-inflammatory medications are commonly used for short-term pain management during flare-ups or while other treatments take effect.
When lifestyle measures and physiotherapy provide insufficient relief, or when pain is severe enough to prevent engagement with rehabilitation, targeted injection therapies can provide meaningful and lasting symptom control. At Joint Care London, all knee injections are performed under real-time ultrasound guidance by experienced musculoskeletal doctors — ensuring precise, accurate placement and optimal outcomes.
Corticosteroid injections deliver a concentrated anti-inflammatory directly into the knee joint. They work by suppressing the inflammatory cascade within the synovium, rapidly reducing pain and swelling. Steroid injections are among the most widely used and well-evidenced treatments for knee OA pain, particularly during acute flare-ups or when significant joint effusion is present.
What to expect: Most patients notice improvement within 3–7 days. Relief typically lasts 4–16 weeks, though individual responses vary considerably. Injections are generally limited to 2–3 per year; frequent repeat injections may accelerate cartilage breakdown over time.
Best suited to: Patients with moderate to severe pain, significant swelling, or acute inflammatory flare-ups. Also useful as a short-term bridge to allow engagement with physiotherapy or while waiting for another treatment to take effect.
Hyaluronic acid (HA) is a naturally occurring substance found in healthy synovial fluid. In an osteoarthritic knee, synovial fluid becomes degraded — thinner, less viscous, and less effective as a lubricant and shock absorber. Viscosupplementation involves injecting high-molecular-weight hyaluronic acid directly into the knee joint to restore these properties.
Unlike steroids, which target inflammation, HA works by improving the mechanical and biological environment of the joint. It provides lubrication, reduces the transmission of mechanical stress to the cartilage surface, and may have mild anti-inflammatory and cartilage-protective effects.
What to expect: Benefits develop more gradually than with steroid injections, typically over 2–4 weeks, but tend to last longer — with relief often sustained for 6–12 months or more in good responders. A single-injection formulation of high-molecular-weight HA is offered at Joint Care London.
Best suited to: Patients with mild to moderate OA who want longer-lasting relief, those who have not responded well to steroids, or those who wish to minimise the use of anti-inflammatory medication.
PRP is prepared by drawing a small sample of the patient's own blood, centrifuging it to concentrate the platelets, and injecting the resulting plasma — rich in growth factors and signalling proteins — into the knee joint. These growth factors are thought to modulate inflammation, promote cartilage cell activity, and support tissue repair.
PRP has attracted significant interest as a potential disease-modifying treatment, rather than purely symptomatic. Evidence is growing, particularly for mild to moderate OA, with a number of studies showing benefits in pain and function comparable or superior to hyaluronic acid.
What to expect: Some patients experience a temporary increase in discomfort for a few days after the injection. Improvement typically emerges over 4–6 weeks, with benefits potentially lasting 6–12 months. A course of 1–3 injections is commonly recommended.
Best suited to: Younger patients with early to moderate OA, those seeking a biologically-based approach, or patients who have not had sustained benefit from other injections.
Read our dedicated article on PRP injections: what they are, how they work, and what to expect.
Arthrosamid is a non-degradable polyacrylamide hydrogel — a relatively new and innovative option for knee osteoarthritis. Unlike conventional injections that are absorbed by the body over weeks or months, Arthrosamid integrates with the synovial membrane (the joint's inner lining), providing a persistent, long-term cushioning and pain-relieving effect from a single injection.
Clinical evidence, including the multicentre TACIT trial, demonstrates sustained improvements in pain and function over 2–3 years. At Joint Care London, our own clinical data shows that approximately 15–50% of patients experience very significant improvement following Arthrosamid injection.
Best suited to: Patients with confirmed mild to moderate knee OA (KL grade 2–3) who have had insufficient or short-lived benefit from steroid or hyaluronic acid injections, and who wish to delay or avoid knee replacement surgery.
For a detailed breakdown of Arthrosamid, including how it compares to other injection options, read our dedicated guide: Arthrosamid for Knee Osteoarthritis: Evidence, Outcomes and How It Compares to Other Treatments.
Surgery is generally considered when pain is severe and constant, quality of life is significantly impaired, and conservative and injection-based treatments have been exhausted. Surgical options for knee OA include:
Keyhole surgery to wash out the joint (lavage), remove loose cartilage fragments, or address concurrent pathology such as a torn meniscus. Evidence for arthroscopy as a treatment for knee OA itself is limited, and it is no longer routinely recommended for OA in the absence of specific mechanical symptoms or confirmed meniscal pathology.
A procedure to realign the knee by removing or adding a wedge of bone above or below the joint. Osteotomy is considered in younger, active patients with unicompartmental OA and significant malalignment, aiming to redistribute load away from the most affected compartment. It can delay the need for joint replacement by many years.
When OA is confined predominantly to one compartment of the knee (most commonly the inner, medial compartment), a partial knee replacement may be appropriate. UKR replaces only the damaged compartment, preserving the healthy areas of the knee and the cruciate ligaments. Recovery tends to be faster than with total knee replacement, and results in a more natural-feeling knee in appropriately selected patients.
Total knee replacement is the definitive surgical treatment for advanced, end-stage knee OA affecting multiple compartments. The damaged joint surfaces of the femur, tibia, and patella are replaced with metal and plastic implants. TKR is one of the most performed and successful elective surgical procedures in the UK, with excellent long-term outcomes for the right patient. However, it involves major surgery with a recovery period of 3–6 months and carries risks including infection, blood clots, stiffness, and implant-related complications. The average implant lifespan is 15–20 years.
A diagnosis of knee osteoarthritis does not mean an inevitable decline into disability. With the right combination of self-management, appropriate treatment, and — where needed — specialist input, the majority of people with knee OA lead active, fulfilling lives for many years.
The following principles have the strongest evidence base for long-term outcomes:
Osteoarthritis is the most common form of arthritis, but "arthritis" is a broader term covering over 100 different joint conditions — including rheumatoid arthritis, gout, and psoriatic arthritis. Knee OA is specifically a degenerative condition caused by cartilage breakdown, distinct from inflammatory arthritis, which is driven by the immune system attacking the joints.
Knee OA does not reverse without intervention — cartilage does not regenerate significantly once lost. However, symptoms can fluctuate considerably. Flare-ups often resolve with rest and appropriate management. With the right treatment and lifestyle changes, many people experience sustained periods of good symptom control and stable disease.
Low-impact aerobic exercise — swimming, cycling, walking, and water aerobics — combined with targeted quadriceps and hip strengthening exercises provides the greatest benefit with least joint stress. High-impact activities such as running or jumping should be modified but not necessarily abandoned entirely, depending on the individual and the severity of OA.
Knee replacement is generally considered when pain is severe, constant (including at rest and at night), significantly impairs daily activities and quality of life, and has not responded to a sustained course of conservative and injection-based management. The decision should be made collaboratively with an orthopaedic surgeon following appropriate imaging and clinical assessment.
Knee injections performed by experienced clinicians under ultrasound guidance are very safe. Risks include temporary post-injection discomfort, infection (very rare when performed under sterile conditions), and — with repeated steroid use — potential effects on the surrounding tissues. Our doctors will discuss the specific risks and benefits of each injection type during your consultation.
Steroid injections typically provide noticeable relief within 3–7 days. Hyaluronic acid and PRP injections tend to work more gradually — over 2–4 weeks — but may provide longer-lasting benefit. Arthrosamid typically shows meaningful improvement at around the four-week mark, with continued gradual improvement over the following months.
This depends on the specific medication and your clinical circumstances. Some blood thinners require temporary adjustment before a joint injection; others do not. This will be reviewed in full during your consultation at Joint Care London before any procedure is undertaken.
At Joint Care London, we provide rapid-access assessment and injection treatment for knee osteoarthritis at our clinics in Notting Hill and Golders Green. We offer the full range of knee injection therapies — steroid, hyaluronic acid, PRP, and Arthrosamid — all performed under real-time ultrasound guidance by experienced musculoskeletal doctors.
We understand that knee pain affects not just your mobility, but your sleep, your work, your independence, and your enjoyment of life. Our goal is to provide fast access to the right treatment for you — with appointments typically available within days, not weeks, and at a fraction of the cost of a private hospital procedure.
If knee pain is holding you back, contact us today to arrange a consultation. Together, we can help you find the most effective approach for your specific situation and get you back to doing the things that matter.